US$ 22.03
is retatrutide prescription only Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide Prescription Online for Weight
Description
In SURMOUNT-1 (72 weeks), tirzepatide produced mean reductions of 15%, 19.5% and 20.9% at the 5, 10 and 15 mg doses versus 3.1% on placebo, and 90.9% of the 15 mg group lost at least 5% of starting weight

If you have insurance that covers GLP-1s, PlushCare makes a lot of sense

A smaller body burns fewer calories, requiring adjustments to diet and exercise

The success of these drugs as a non-invasive treatment for obesity has led to an estimated decrease of 15% in bariatric surgeries

doi: 10.2337/dcS13-2004 90 ElashoffMMatveyenkoAVGierBElashoffRButlerPC

Ther., vol
